IPN60300

· Ipsen

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for IPN60300, covering 2026-04-01 to 2026-04-01. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Assess the Safety, Tolerability, Pharmacokinetic, Pharmacodynamic, Immunogenicity and Antitumour Activity of IPN60300 in Adults With Locally Advanced or Metastatic Solid Tumours [Phase 1, Phase 2]

See pricing